- Home
- CRDF vs EVG Comparison
CRDF vs EVG Comparison
Compare CRDF & EVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- EVG
- Stock Information
- Founded
- CRDF 1999
- EVG 2005
- Country
- CRDF United States
- EVG United States
- Employees
- CRDF N/A
- EVG N/A
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- EVG Investment Managers
- Sector
- CRDF Health Care
- EVG Finance
- Exchange
- CRDF Nasdaq
- EVG Nasdaq
- Market Cap
- CRDF 144.4M
- EVG 148.1M
- IPO Year
- CRDF N/A
- EVG N/A
- Fundamental
- Price
- CRDF $2.05
- EVG $11.40
- Analyst Decision
- CRDF Strong Buy
- EVG
- Analyst Count
- CRDF 5
- EVG 0
- Target Price
- CRDF $11.10
- EVG N/A
- AVG Volume (30 Days)
- CRDF 1.1M
- EVG 49.4K
- Earning Date
- CRDF 11-06-2025
- EVG 01-01-0001
- Dividend Yield
- CRDF N/A
- EVG 8.68%
- EPS Growth
- CRDF N/A
- EVG N/A
- EPS
- CRDF N/A
- EVG N/A
- Revenue
- CRDF $545,000.00
- EVG N/A
- Revenue This Year
- CRDF N/A
- EVG N/A
- Revenue Next Year
- CRDF N/A
- EVG N/A
- P/E Ratio
- CRDF N/A
- EVG N/A
- Revenue Growth
- CRDF N/A
- EVG N/A
- 52 Week Low
- CRDF $1.90
- EVG $9.13
- 52 Week High
- CRDF $5.64
- EVG $10.86
- Technical
- Relative Strength Index (RSI)
- CRDF 36.50
- EVG 63.24
- Support Level
- CRDF $2.03
- EVG $11.18
- Resistance Level
- CRDF $2.27
- EVG $11.45
- Average True Range (ATR)
- CRDF 0.12
- EVG 0.07
- MACD
- CRDF 0.04
- EVG 0.00
- Stochastic Oscillator
- CRDF 31.91
- EVG 81.48
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.
About EVG Eaton Vance Short Diversified Income Fund Eaton Vance Short Duration Diversified Income Fund of Beneficial Interest
Eaton Vance Short Duration Diversified Income Fund is a diversified, closed-end management investment company. Its primary investment objective is to provide a high level of current income with a secondary objective of seeking capital appreciation to the extent consistent with its primary goal. The portfolio of investments consists of business equipment and services, automotive, cable and satellite television, chemicals and plastics, food products, and other areas.